Nav: Home

High stability of the hepatitis B virus

October 30, 2018

At room temperature, hepatitis B viruses (HBV) remain contagious for several weeks and they are even able to withstand temperatures of four degrees centigrade over the span of nine months. When applied properly, disinfectants are effective - but only undiluted. These are the results gained by a German-Korean research team in a study using a novel HBV infection system in human liver cells. Due to a lack of human research models, research had previously been conducted in duck hepatitis B viruses. Professor Eike Steinmann from the Department for Molecular & Medical Virology at Ruhr-Universität Bochum (RUB) and RUB alumnus Professor Marc Windisch from the Institute Pasteur Korea in Seoul published their report in the Journal of Infectious Diseases on October 24, 2018.

Recurring infections

Hepatitis B is primarily transmitted through contact with blood. "Consequently, it should be easy to control, provided appropriate hygiene measures are implemented," says Eike Steinmann. However, there are frequently cases of people contracting the hepatitis B virus in hospitals or in the workplace.

Previously: duck viruses only

Attempting to find out why, researchers had hitherto been forced to make use of the duck hepatitis B virus, which is related to the human virus. "However, those studies have only ever permitted rough estimates as far as the infectiosity of HBV is concerned," points out Steinmann. For their analyses, he and his colleagues utilised an HBV infection system in human liver cells, developed recently at the Institute Pasteur Korea, in order to obtain more realistic results. "The new HBV infection system enables researchers worldwide to finally conduct highly detailed studies of the human virus that had not been possible until quite recently," explains Marc Windisch.

Common hand disinfectants are effective

Using this model, the researchers were able to demonstrate that the infectivity of HBV barely decreases at room temperature even after a few weeks, and that it remains highly stable at four degrees centigrade over a period of nine months. "Various alcohols and off-the-shelf hand sanitisers deactivate the viruses," says Eike Steinmann. "If the disinfectants are diluted, however, their deactivating properties are reduced. Luckily, diluting disinfectants is not common practice."

More resilient than all others

The researchers compared the efficacy of two alcohol-based WHO-recommended hand sanitisers against different viruses that have an envelope, such as the HBV. The comparison viruses included the Ebola virus and the hepatitis C virus. "Among all tested viruses, HBV demonstrated the highest resilience against both disinfectants," stresses Marc Windisch, Head of the Applied Molecular Virology Laboratory at the Institute Pasteur in Seoul.

The researchers recommend strict compliance with hygiene guidelines, in order to prevent HBV infections in the future.
-end-
Hepatitis B

Worldwide, approx. 290 million people are chronically infected with the hepatitis B virus. This means hepatitis B is one of the most widely spread infectious diseases. The virus can cause both acute and chronic liver diseases. Due to the consequences of severe liver diseases, the virus leads to great number of deaths each year.

Original publication

Thoa Thi Than, Eunji Jo, Daniel Todt, Phuong Hong Nguyen, Jochen Steinmann, Eike Steinmann, Marc P Windisch: High environmental stability of hepatitis B virus and inactivation requirements for chemical biocides, in: Journal of Infectious Diseases, 2018, DOI: 10.1093/infdis/jiy620

Press contact

Prof. Dr. Eike Steinmann
Department for Molecular & Medical Virology
Faculty of Medicine
Ruhr-Universität Bochum
Phone: +49 234 32 28189
Email: eike.steinmann@rub.de

Prof. Dr. Marc P. Windisch
Executive Director - Discovery Biology Division
Institute Pasteur Korea
South Korea
Phone: +82 31 8018 8080
Email: marc.windisch@ip-korea.org

Ruhr-University Bochum

Related Hepatitis Articles:

Nanotechnology delivers hepatitis B vaccine
X-ray imaging shows that nanostructured silica acts as a protective vehicle to deliver intact antigen to the intestine so that it can trigger an immune response.
Checkmate for hepatitis B viruses in the liver
Researchers at Helmholtz Zentrum München and the Technical University of Munich, working in collaboration with researchers at the University Medical Center Hamburg-Eppendorf and the University Hospital Heidelberg, have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model.
How common is Hepatitis C infection in each US state?
Hepatitis C virus infection is a major cause of illness and death in the United States and injection drug use is likely fueling many new cases.
New strains of hepatitis C found in Africa
The largest population study of hepatitis C in Africa has found three new strains of the virus circulating in the general population in sub-Saharan Africa.
High stability of the hepatitis B virus
At room temperature, hepatitis B viruses (HBV) remain contagious for several weeks and they are even able to withstand temperatures of four degrees centigrade over the span of nine months.
Findings could lead to treatment of hepatitis B
Researchers have gained new insights into the virus that causes hepatitis B -- a life-threatening and incurable infection that afflicts more than 250 million people worldwide.
How to cure more hepatitis C patients
The cost of cures for hepatitis C have been prohibitive, but experts who served on an NAS panel have a solution that will save more patients and incentivize drug innovation.
Hepatitis C: A novel point-of-care assay
One of the major challenges identified by the WHO in efforts to eradicate the hepatitis C virus is the diagnosis of chronic cases that are generally asymptomatic.
Countries risk 'running out' of hepatitis C patients to treat, says World Hepatitis Alliance
The latest data on the global hepatitis C epidemic, released today at the World Hepatitis Summit in Sao Paulo, Brazil, reveal that most countries (especially high-income countries) are running out of patients to treat because of the low diagnosis rates worldwide.
Australia currently on track to eliminate hepatitis C by 2030, but challenges remain for hepatitis B
New data released at this year's World Hepatitis Summit in Sao Paulo, Brazil, shows that Australia is currently on track to eliminate hepatitis C thanks to its huge efforts to enable population-wide access to treatment.
More Hepatitis News and Hepatitis Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Risk
Why do we revere risk-takers, even when their actions terrify us? Why are some better at taking risks than others? This hour, TED speakers explore the alluring, dangerous, and calculated sides of risk. Guests include professional rock climber Alex Honnold, economist Mariana Mazzucato, psychology researcher Kashfia Rahman, structural engineer and bridge designer Ian Firth, and risk intelligence expert Dylan Evans.
Now Playing: Science for the People

#540 Specialize? Or Generalize?
Ever been called a "jack of all trades, master of none"? The world loves to elevate specialists, people who drill deep into a single topic. Those people are great. But there's a place for generalists too, argues David Epstein. Jacks of all trades are often more successful than specialists. And he's got science to back it up. We talk with Epstein about his latest book, "Range: Why Generalists Triumph in a Specialized World".
Now Playing: Radiolab

Dolly Parton's America: Neon Moss
Today on Radiolab, we're bringing you the fourth episode of Jad's special series, Dolly Parton's America. In this episode, Jad goes back up the mountain to visit Dolly's actual Tennessee mountain home, where she tells stories about her first trips out of the holler. Back on the mountaintop, standing under the rain by the Little Pigeon River, the trip triggers memories of Jad's first visit to his father's childhood home, and opens the gateway to dizzying stories of music and migration. Support Radiolab today at Radiolab.org/donate.